問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
賴學洲
下載
2019-05-01 - 2029-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting3Sites
Terminated3Sites
2020-03-01 - 2028-12-31
Participate Sites8Sites
Recruiting8Sites
2023-11-09 - 2032-11-22
Participate Sites7Sites
Recruiting7Sites
2024-12-01 - 2029-03-31
Participate Sites9Sites
Recruiting9Sites
2020-05-18 - 2023-12-31
Recruiting6Sites
2022-06-01 - 2029-01-31
Participate Sites4Sites
Recruiting4Sites
2019-11-30 - 2026-09-30
2022-06-01 - 2026-12-31
Not yet recruiting1Sites
Recruiting5Sites
2024-01-12 - 2026-09-11
Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Efruxifermin
Not yet recruiting4Sites
Recruiting2Sites
Study ended1Sites
2019-08-01 - 2021-11-03
Chronic Hepatitis B
HLX10
Participate Sites3Sites
全部
